Product Description

Indications:Mirakof is used to relieve dry (non-productive) cough, including cough caused by viral infections. It is also used in pre- and post-operative cough, bronchoscopy procedures, whooping cough and cough associated with acute respiratory tract infections such as bronchitis, laryngitis and tracheitis.Pharmacology:Butamirate citrate acts directly on the brain’s cough center to suppress cough. It is non-opioid, non-sedating and not related to opium alkaloids. It is rapidly absorbed, highly protein-bound and has a half-life of about 13 hours. Its active metabolites also contribute to cough suppression.Dosage and Administration:Adults: 50 mg tablets 2–3 times daily or syrup 15 mL four times daily.Adolescents (>12 years): 1–2 tablets daily or syrup 15 mL three times daily.Children:6–12 years: 10 mL syrup three times daily3–6 years: 5 mL syrup three times daily2 months–3 years: pediatric drops 0.5–0.75 mL four times dailyDrug Interactions:Avoid use with expectorants, as it may cause mucus retention in the airways.Contraindications:Contraindicated in patients with hypersensitivity to butamirate citrate.Side Effects:Generally well tolerated. Rare side effects include rash, nausea, diarrhea and dizziness, which usually resolve after dose adjustment or discontinuation.Pregnancy and Lactation:Not recommended during the first trimester of pregnancy. Use with caution in later pregnancy. Use during breastfeeding only if benefits outweigh risks.Precautions and Warnings:Avoid combining with expectorants. If cough persists for more than 7 days (or more than 3 days in children), consult a doctor.Overdose Effects:Overdose may cause drowsiness, nausea, vomiting, diarrhea, loss of balance and low blood pressure. Management includes supportive treatment and emergency care.Therapeutic Class:Cough SuppressantStorage Conditions:Store below 30°C, protect from light and moisture, and keep out of reach of children.⚠️ Use under the advice of a registered healthcare professional.